Impact of Different Separation Methods on Proximal Contact Tightness and Contour of Compound Class ii

September 18, 2024 updated by: Hadeer Hesham Mohamed, Cairo University

Impact of Different Separation Methods on Proximal Contact Tightness and Contour of Compound Class ii Nanohybrid Resin Composite Restorations: Randomized Clinical Trial

The aim of this study is to evaluate the interdental separation of various separation systems and their impact on the proximal contact tightness and contour in compound class II nanohybrid resin composite restorations.

Study Overview

Detailed Description

The target population consists of adult patients aged 25-40, with posterior compound proximal carious cavities (ICDS score 4 or 5) in molars. The interventions under investigation include three different separation systems: the Resin ring (DR-Resin ring, Egypt), Elliot separator (Pfingst & Co, USA), and Stainless Steel Metal ring (TOR VM ring, Russia). These systems will be compared to a Nickel titanium 3D-fusion ring (Garrison, USA). The primary outcomes assessed are proximal contact tightness and form/contour, measured visually according to FDI criteria, with scoring systems adapted from Hickel et al. (2023). Secondary outcomes, such as patient comfort (measured by a pain rating scale), and the emergence profile (assessed via bitewing radiographs), will also be considered. Data will be collected immediately postoperatively (T0), at 30 days (T1), and after 6 months (T2). The study will be conducted as a randomized clinical trial. The null hypothesis suggests that there will be no significant differences in proximal contact tightness or contour across the different separation systems used.

Study Type

Interventional

Enrollment (Estimated)

160

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Individuals with posterior compound proximal carious cavities in molars.
  2. Age of (25-40) years.
  3. Molars with compound proximal carious cavities score 4 or 5 ICDS.
  4. Vital upper or lower posterior teeth with no signs of irreversible pulpitis.
  5. Presence of adjacent and opposing teeth with normal occlusion

Exclusion Criteria:

  1. Patients with major systemic disorders or xerostomia.
  2. Patients with periodontal disease.
  3. Patients with para-functional habits.
  4. Presence of malocclusion or signs of pathological teeth wear
  5. Non vital teeth or teeth with signs of pulpal pathology.
  6. Teeth mobility or clinical attachment loss.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: C (comparator)
Nickel titanium 3D-fusion ring (Garrison, USA)
Nickel titanium 3D-fusion ring (Garrison, USA)
Experimental: I1 (Intervention)
Resin ring (DR- Resin ring, Egypt)
Resin ring (DR- Resin ring, Egypt)
Experimental: I2 (Intervention)
Elliot separator (Pfingst & Co, South Plainfield, NJ, USA)
Elliot separator (Pfingst & Co, South Plainfield, NJ, USA)
Experimental: I3 (Intervention)
Stainless Steel Metal ring (TOR VM ring, Moscow, Russia)
Stainless Steel Metal ring (TOR VM ring, Moscow, Russia)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Proximal Contact tightness (Success rate)
Time Frame: From enrollment to the end of treatment at 6 months
Visual examination and 25-/50-/100-µm blade according to FDI Criteria
From enrollment to the end of treatment at 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Form and Contour
Time Frame: From enrollment to the end of treatment at 6 months
Visual examination according to FDI Criteria
From enrollment to the end of treatment at 6 months
Patient Comfort
Time Frame: From enrollment to the end of treatment at 6 months
Pain rating scale
From enrollment to the end of treatment at 6 months
Emergence profile
Time Frame: From enrollment to the end of treatment at 6 months
Bitewing Radiographs
From enrollment to the end of treatment at 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Hadeer H Mohamed, MSC. degree, Assistant Lecturer of Conservative Dentistry, Faculty of Dentistry Cairo University, Egypt.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

January 1, 2025

Primary Completion (Estimated)

June 30, 2025

Study Completion (Estimated)

January 1, 2026

Study Registration Dates

First Submitted

September 18, 2024

First Submitted That Met QC Criteria

September 18, 2024

First Posted (Actual)

September 23, 2024

Study Record Updates

Last Update Posted (Actual)

September 23, 2024

Last Update Submitted That Met QC Criteria

September 18, 2024

Last Verified

September 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • IMPACT OF SEPARATION METHODS

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Proximal Caries

Clinical Trials on C (comparator)

Subscribe